NGVT — Ingevity Corp
—
NYSE ·
Materials ·
Chemicals ·
CIK 1653477 ·
Last close
$68.81
Market Cap
$2.37B
52W High
$79.05
52W Low
$65.06
ADV30
240,373
Next earnings
2026-07-29
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 258,000,000 | 116,400,000 | 69,000,000 | 59,800,000 | 1,650,200,000 | 95,400,000 | 1,611,300,000 |
| Dec 2025 | 255,100,000 | 87,800,000 | 38,800,000 | -84,600,000 | 1,651,100,000 | 78,100,000 | 1,621,400,000 |
| Sep 2025 | 333,100,000 | 133,900,000 | 82,800,000 | 43,500,000 | 1,833,800,000 | 83,400,000 | 1,695,700,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$211,000,000
Investing CF
$138,500,000
Financing CF
$-277,600,000
CapEx
$-56,100,000
Dividends Paid
—
Buybacks
$-143,100,000
EPS Diluted TTM
$1.47
As of
2026-08-02
Balance + Analyst (yfinance extras)
Retained Earnings
$500,000,000
Inventory
$154,000,000
Receivables
$155,800,000
ST Investments
—
EBIT TTM
$106,300,000
Pretax Income TTM
$37,700,000
Interest Exp TTM
$68,600,000
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,160,300,032
EBITDA
$372,600,000
Free Cash Flow
$88,937,504
Enterprise Value
$3,554,636,544
Total Cash
$97,400,000
Total Debt
$1,236,300,032
Shares Out
34,377,922
Trailing EPS
$0.71
Book Value
$1.36
ROE
30.1%
ROA
10.4%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,167,600,000 | 261,900,000 | -167,100,000 | 1,651,100,000 | 1,621,400,000 | — | 331,200,000 |
| Dec 2024 | 1,200,100,000 | 282,500,000 | -430,300,000 | 2,022,600,000 | 1,827,400,000 | — | 128,600,000 |
| Dec 2023 | 1,215,500,000 | 257,800,000 | -5,400,000 | 2,623,300,000 | 1,991,900,000 | — | 205,100,000 |
| Dec 2022 | 1,668,300,000 | 341,000,000 | 211,600,000 | 2,736,500,000 | 2,038,200,000 | — | 313,400,000 |
TTM Snapshot
Revenues TTM
$1,638,600,000
NetIncome TTM
$-10,800,000
OpCashFlow TTM
$0
Assets (Latest)
$2,022,600,000
Forward EPS
$6.01
Max Pain — expiry 2026-10-16 (volume-derived — Yahoo OI feed degraded)
max pain strike: $50.00 · spot: $68.81 · call volume: 39 · put volume: 0Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| IOSP | INNOSPEC INC. | $2.33B | $94.73 | — |
| CC | Chemours Co | $2.32B | $15.39 | — |
| COTY | COTY INC. | $2.46B | $2.79 | — |
| CURLF | Curaleaf Holdings, Inc. | $2.26B | $9.68 | — |
| MTX | MINERALS TECHNOLOGIES INC | $2.24B | $71.93 | — |
News headlines (Yahoo Finance, 1h cache)
Ingevity included in TIME America’s Best Companies 2026 list
2026-08-18 13:00 · Yahoo
Ingevity (NGVT) Q2 2026 Earnings Call Transcript
2026-08-08 01:28 · Yahoo
NGVT Q2 Earnings Beat on Pricing, Mix and Higher Volumes
2026-08-06 14:08 · Yahoo
Ingevity Releases 2025 Sustainability Report, Highlights Performance and Impact
2026-08-05 13:00 · Yahoo
Is Ingevity (NGVT) Cheap On Earnings And Its Completed Buyback?
2026-08-03 03:16 · Yahoo
What Ingevity (NGVT)'s Profit Rebound and Major Buyback Mean For Shareholders
2026-08-03 00:16 · Yahoo
Ingevity Q2 Earnings Call Highlights
2026-07-31 22:03 · Yahoo
Ingevity (NGVT) Tops Q2 Earnings and Revenue Estimates
2026-07-30 00:35 · Yahoo
Ingevity’s Evotherm® P35 receives BASt approval in Germany
2026-07-16 16:49 · Yahoo
Ingevity Corporation Q2 2026 Earnings Call Summary
2026-07-30 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.